Showing all 2 results

  • Ondansetron Orally Disintegrating Tablets, Ondansetron Orally Disintegrating Tablets 4mg, Ondansetron ODT 8mg, Zofran Zydis Generic, Vomikind-MD Generic, Emeset-MD Generic, Melt-in-Mouth Anti-Emetic, Mouth Dissolving Tablet, Chemotherapy Nausea Medicine, Post-Op Vomiting Drug, 5-HT3 Antagonist, Cancer Care Medicine, Pediatric Vomiting Relief, CAS 99614-01-4, Healthy Inc Oncology Medicines, WHO GMP Certified Tablet Unit, Contract Manufacturing Ondansetron, Third Party Manufacturing Pharma, Hospital Bulk Supply Oncology, Ministry of Health Tender, Government Tender Pharma Supplier, NGO Medicine Procurement, Emergency Room Supply, HS Code 30049099, Ondansetron Supplier Africa, Anti-Emetic Exporter Philippines, Ondansetron USP BP, Medicine Export to Africa, Pharmaceutical Drop Shipper, B2B Pharma Marketplace, Medicine Export to LATAM, Tabletas de Ondansetrón Dispersable, Tabletas para Vómitos, Comprimés d'Ondansétron Orodispersible, Antiémétique, Medicamento Quimioterapia, Tratamiento Náuseas, Comprimidos de Ondansetrona, Medicamentos Oncológicos, Ондансетрон таблетки, Противорвотные средства, Лечение тошноты, أقراص أوندانسيترون, دواء القيء, مضاد للغثيان, オンダンセトロン口腔内崩壊錠, 制吐剤, 抗がん剤副作用対策, 昂丹司琼口腔崩解片, 止吐药, Zufer-MD Generic, Periset Generic, Global Pharmaceutical Suppliers Africa LATAM
    Ondansetron Tablets
    In Stock
    Quick View
    , ,

    Ondansetron Orally Disintegrating Tablets

    Free

    Product Composition & Available Formats

    We supply Ondansetron ODT in the two primary compendial configurations required to support initial introductory pediatric dosing up to high-potency surgical and oncological maintenance regimens.

    Active Ingredient MonographAvailable StrengthsFormulation Delivery MatrixPrimary Clinical Application
    Ondansetron Base / Hydrochloride USP / BP / IP4 mgFast-Dispersing Hydrophilic Matrix (ODT)Pediatric & General Antiemetic: First-line baseline dosing for acute gastroenteritis, pediatric oncology protocols, and mild post-operative nausea.
    Ondansetron Base / Hydrochloride USP / BP / IP8 mgFast-Dispersing Hydrophilic Matrix (ODT)High-Potency Emetic Control: Advanced strength engineered for highly emetogenic chemotherapy cycles, abdominal radiation protocols, and immediate post-surgical recovery fields.
    Read more
  • Placeholder
    In Stock
    Quick View
    , ,

    Ondansitron Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.

    Active IngredientStrengthPrimary Clinical Function
    Ondansetron (as HCl Dihydrate) Ph.Eur./USP4 mg (ODT / FCT)Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers.
    Ondansetron (as HCl Dihydrate) Ph.Eur./USP8 mg (ODT / FCT)Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV).
    Excipients (ODT Formulation)Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint FlavoringLyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste)

    *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).

    Read more